Compound research hub
Sermorelin: Research, Handling and Batch Documentation
Sermorelin is GHRH(1-29) amide, the shortest fragment of growth-hormone-releasing hormone that retains full activity at the GHRH receptor.
Part of Volta's peptides.
Identity and specification
- Form
- Lyophilized powder
- Appearance
- White lyophilised powder
- Other known names
- GRF 1-29, Sermorelin Acetate
- Compound class
- GHRH analogue (GHRH receptor agonist)
- CAS number
- 86168-78-7
- Molecular formula
- C₁₄₉H₂₄₆N₄₄O₄₂S
- Molecular weight
- 3,357.9 g/mol
- PubChem CID
- 16129620
- Production
- Synthetic, by solid-phase peptide synthesis
- Solubility
- Soluble in sterile water
- Shelf life
- 24 months from date of manufacture
Molecular structure, sequence and the published laboratory studies on Sermorelin are in the compound library entry for Sermorelin.
Vial sizes available
Every size of Sermorelin Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.
- In stock
Sermorelin 10mg 10mgBatch #: VPSR10100 - Restocking
Sermorelin 5mg 5mgBatch #: VPSR5100
Purity and batch documentation
Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.
No third-party certificate has been published for Sermorelinyet. The certificates Volta does publish, with the laboratory's own verification link on each, are in the certificate archive.
Research on Sermorelin
Handling and stability
Laboratory guides
Regulatory context
More peptides
Sermorelin sits in Volta's peptides group, alongside the other compounds of the same composition. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.